Search results for "PLACEBO"

showing 10 items of 704 documents

The Efficacy and Safety of Topiramate in the Prevention of Pediatric Migraine: An Update Meta-Analysis

2020

Background: Migraine is the most common acute primary headache in children and adolescents. In 2014, topiramate became the first preventive drug for migraine, approved by the Food and Drug Administration (FDA) for adolescents. This meta-analysis was aimed to evaluate the efficacy and safety of topiramate in the prevention of pediatric migraine.Methods: We searched the PubMed, EMBASE, Cochrane Library, and Chinese National Knowledge Infrastructure (CNKI) databases up to June 2019 for eligible randomized controlled trials (RCTs). The primary outcomes were mean migraine days per month, ≥50% reduction rate, and Pediatric Migraine Disability Assessment Scale (PedMIDAS) scores. RevMan5.3 software…

Topiramatemedicine.medical_specialtytopiramate030204 cardiovascular system & hematologyCochrane LibraryPlaceboPediatricslaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialpreventionlaw030225 pediatricsInternal medicinemedicinemigraineAdverse effectResponse rate (survey)business.industrylcsh:RJ1-570lcsh:Pediatricsmedicine.diseasemeta-analysispediatricMigraineMeta-analysisPediatrics Perinatology and Child HealthSystematic Reviewbusinessmedicine.drugFrontiers in Pediatrics
researchProduct

Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials

2017

Numerous studies have investigated aripiprazole as a treatment for bipolar disorder (BD). therefore we conducted this comprehensive meta-analysis to investigate the efficacy and safety profile of aripiprazole in treating BD. Two authors conducted systematic searches of PubMed and ScienceDirect from inception until May 14th, 2017. Randomized controlled trials (RCTs) of people with BD who received aripiprazole were included. A total of 20 RCTs met the eligibility criteria, including two which investigated the efficacy of aripiprazole versus haloperidol (aripiprazole = 340; haloperidol = 337), three which compared aripiprazole versus lithium (aripiprazole = 208; lithium = 212), and 15 with mul…

Transtorno Bipolarmedicine.medical_specialtyEfficacyBipolar disorderAripiprazolePlacebolaw.invention03 medical and health sciences0302 clinical medicineMaintenance therapyRandomized controlled trialAripiprazole; Bipolar disorder; Efficacy; Meta-analysis; Tolerability; Pharmacology; Biological PsychiatrylawInternal medicinemedicineHaloperidolHumansMeta-analysiBipolar disorderPsychiatryBiological PsychiatryRandomized Controlled Trials as TopicAripiprazole Bipolar disorder Efficacy Tolerability Meta-analysisPharmacologymedicine.diseaseTolerability030227 psychiatryMeta-analysisAripiprazolTolerabilityMeta-analysisAripiprazolePsychology030217 neurology & neurosurgeryAntipsychotic Agentsmedicine.drug
researchProduct

Effets d'une complémentation nutritionnelle en vitamines et minéraux sur la chute de force et les marqueurs biologiques consécutifs à un exercice exc…

2007

Purpose. – The effects of vitamins and minerals complex supplementation on maximal voluntary contraction decrease (FMV) and biological markers following an eccentric exercise at old people. Method. – Sixteen elderly subjects took either placebo (Pl group) or vitamins and minerals (Isoxan Senior, NHS, Rungis, France) (group S) for 21 d before an eccentric exercise and for 3 d after the exercise. The FMV and surface EMG activity (RMS) of the vastus lateralis (VL), vastus medialis (VM) and rectus femoris (RF) were recorded before (Pre), immediately after (Post), 24 h (Post 24) and 48 h (Post 48) after the exercise. CCVThe creatine kinase (CK), lactate deshydrogenase, malondialdehyde, and tumor…

Vitaminmedicine.medical_specialtybiologyVastus medialisbusiness.industry030229 sport sciencesMalondialdehydePlaceboSurgery03 medical and health scienceschemistry.chemical_compound0302 clinical medicineVoluntary contractionEndocrinologychemistryEccentric exerciseInternal medicinemedicinebiology.proteinOrthopedics and Sports MedicineCreatine kinaseDietary supplementationbusiness030217 neurology & neurosurgeryScience & Sports
researchProduct

Photobiomodulation Therapy in the Management of Burning Mouth Syndrome: Morphological Variations in the Capillary Bed

2020

Burning mouth syndrome (BMS) is an idiopathic condition that manifests itself primarily with the onset of a burning sensation. The aim of this research was to perform photobiomodulation therapy (PBM) using a diode laser on the oral mucosa of BMS patients, followed by an objective evaluation of the morphological changes in the vascular bed underlying the mucosa using polarized light videocapillaroscopy. A group of 40 patients were included in the study. The patients were randomly divided into two groups (using simple randomization) as follows: 20 patients were assigned to the laser group and 20 patients were assigned to the placebo group. Each patient of the laser group received eight irradi…

burning mouth syndromeRandomizationphotobiomodulation therapyCapillary actionPlaceboBuccal mucosaArticlelaw.inventiondiode laser030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinelawmedicineOral mucosaGeneral Dentistrydentistrybusiness.industry030206 dentistryvideocapillaroscopyBurning mouth syndromeLaserlcsh:RK1-715medicine.anatomical_structurelcsh:DentistryEnergy densitymedicine.symptombusinessNuclear medicine
researchProduct

The use of rapid onset opioids for breakthrough cancer pain: the challenge of its dosing.

2011

Breakthrough cancer pain (BTcP) has been defined as a transitory increase in pain intensity on a baseline pain of moderate intensity in patients on analgesic treatment regularly administered. This review provides updated information about the use of opioids for the treatment of BTcP, with special emphasis on the use of new rapid onset opioids (ROOs). Due to its slow onset to effect oral opioids cannot be considered an efficacious treatment for BTcP. Parenteral opioids may provide rapid onset of analgesia, but not always available particularly at home. Different technologies have been developed to provide fast pain relief with potent opioid drugs such fentanyl, delivered by non-invasive rout…

business.industryDrug Administration RoutesAnalgesicBreakthrough PainHematologyBuccal administrationPlaceboFentanylAnalgesics OpioidOncologyOpioidAnesthesiaNeoplasmsmedicineHumansPain ManagementNasal administrationDosingCancer painbusinessmedicine.drugCritical reviews in oncology/hematology
researchProduct

Effects of Caffeine as an Adjuvant to Morphine in Advanced Cancer Patients

2001

Psychomotor abnormalities are one of the complications of opioid therapy in advanced cancer patients. Caffeine has potential properties to counteract the central effects of morphine. Twelve patients receiving stable doses of slow release morphine with adequate pain relief were scheduled for this double-blind placebo-controlled crossover trial. The treatment consisted of an intravenous dose of 1/6 of the daily morphine dose, using an intravenous/oral conversion ratio of 1:3. The dose calculated was administered in 5 minutes. Patients were randomly divided to received in a double-blind manner an infusion of 200 mg of caffeine or saline solution intravenously over one hour. A crossover took pl…

business.industryPlacebo-controlled studyPlaceboCrossover studychemistry.chemical_compoundAnesthesiology and Pain MedicineBolus (medicine)chemistryOpioidAnesthesiamedicineMorphineNeurology (clinical)CaffeineCancer painbusinessGeneral Nursingmedicine.drugJournal of Pain and Symptom Management
researchProduct

The influence of topic and systemic administration of copaiba oil on the alveolar wound healing after tooth extraction in rats

2013

Submitted by Vitor Silverio Rodrigues (vitorsrodrigues@reitoria.unesp.br) on 2014-05-27T11:30:51Z No. of bitstreams: 0Bitstream added on 2014-05-27T14:43:39Z : No. of bitstreams: 1 2-s2.0-84885131306.pdf: 482007 bytes, checksum: 4123ac7ef46e4992cfe3739bf69580ee (MD5) Made available in DSpace on 2014-05-27T11:30:51Z (GMT). No. of bitstreams: 0 Previous issue date: 2013-10-14 The Copaiba oil has been used as an auxiliary treatment of inflammations, skin disorders and stomach ulcers, however, in dentistry, this alternative medicine has not been investigated yet. The purpose of this study was to evaluate the influence of topic and systemic administration of copaiba oil on the alveolar wound hea…

business.industryResearchDentistryConnective tissueOdontología:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludPlacebo groupAlveolar wound healingCopaiba OilOil-resinmedicine.anatomical_structureClinical and Experimental DentistryUNESCO::CIENCIAS MÉDICASCopaibaCopaibaSystemic administrationMedicineStomach ulcersbusinessWound healingGeneral DentistryDental alveolusJournal of Clinical and Experimental Dentistry
researchProduct

The clomethiazole acute stroke study (CLASS): Safety results in 1,356 patients with acute hemispheric stroke.

2000

The Clomethiazole Acute Stroke Study (CLASS) showed no difference in outcome between patients treated with clomethiazole or placebo for all patients treated, but a beneficial effect in patients classified as a total anterior circulation syndrome (TACS). These are patients with clinical symptoms of a large stroke. Safety and tolerability data are reported here with emphasis on the safety of treating stroke patients with a sedative drug. In total, 1,356 patients were eligible for safety analysis. Mortality at 90 days was equal between the treatment groups (clomethiazole, 19.5%; placebo, 19.7%). Clomethiazole was generally well-tolerated. The most common adverse event was sedation (clomethiazo…

business.industrySedationRehabilitationPlacebomedicine.diseaseClinical trialBlood pressureTolerabilityAnesthesiaClomethiazoleMedicineSurgeryNeurology (clinical)medicine.symptomCardiology and Cardiovascular MedicinebusinessAdverse effectStrokemedicine.drugJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
researchProduct

Effect of preemptive analgesia with ibuprofen in the control of postoperative pain in dental implant surgeries: A randomized, triple-blind controlled…

2019

Background Preemptive analgesia has as its basic principle the administration of analgesics before the onset of painful stimuli, in order to reduce or prevent postoperative pain, but this question is little explored in implantology. Thus, this study was conducted in order to evaluate the clinical efficacy of ibuprofen in pain prevention after unit implant surgery. Material and Methods For this triple-blind, parallel, placebo-controlled and randomized clinical trial, 54 insertion surgeries of unitary implants were performed. Two groups have received two different protocols 1 hour before surgery: Ibuprofen group (IBU) 600 mg of ibuprofen; and (2) placebo group (maize starch). The intensity of…

business.industryVisual analogue scaleResearchmedicine.medical_treatmentPostoperative pain030206 dentistry:CIENCIAS MÉDICAS [UNESCO]IbuprofenPlacebolaw.inventionClinical trial03 medical and health sciences0302 clinical medicineRandomized controlled triallawAnesthesiaUNESCO::CIENCIAS MÉDICASmedicineAnalysis of varianceOral SurgeryDental implantbusinessGeneral Dentistry030217 neurology & neurosurgerymedicine.drugJournal of Clinical and Experimental Dentistry
researchProduct

Separating efficacy and sedative effects of guanfacine extended release in children and adolescents with ADHD from four randomized, controlled, phase…

2016

IntroductionGuanfacine extended release (GXR) is a non-stimulant treatment for attention-deficit/hyperactivity disorder (ADHD).ObjectiveTo separate efficacy and sedative treatment-emergent adverse events (TEAEs) associated with GXR in four randomized, controlled trials in children (6–12 years) and adolescents (13–17 years) with ADHD.MethodsSPD503-301 (n = 345) and SPD503-304 (n = 324) were 8 and 9 week studies of fixed-dose GXR (≤ 4 mg/day). SPD503-312 (n = 314; adolescents only) and SPD503-316 (n = 338) were 10–13 week studies of dose-optimized GXR (1–7 mg/day).ResultsIn fixed-dose studies, pooled incidences of sedative TEAEs with GXR were highest at week 1 (GXR, 13.9–18.7%; placebo, 8.7%)…

business.industrymedicine.drug_classSedationPlaceboGuanfacineClinical trialPsychiatry and Mental healthAnesthesiaSedativemedicineDosingmedicine.symptomExtended releasebusinessAdverse effectmedicine.drugEuropean Psychiatry
researchProduct